|Administrative Titles:||Professor, Dept. of Medcial Microbiology, Immunology and Cell Biology|
|University of Iowa
University of South Dakota
South Dakota State University
|Special Interests:|| otoprotective agents, noise-induced hearing loss,
drug-induced hearing loss
|Funding Totals:||More than $11 million|
|Major Funding Agencies:||Department of Defense, Veterans Administration, the Illinois Department of Public Health and the National Institutes of Health/National Institute of Aging and National Institute of Deafness and Communication Disorders|
Kathleen Campbell, Ph.D., Distinguished Scholar and Professor in the Department of Medical Microbiology, Immunology and Cell Biology at SIU School of Medicine, served on the American Academy (AAA) Board of Directors, received an AAA Presidential Citation, two Medical Innovators Awards and is an American Speech Language Hearing Association (ASHA) fellow. She was the 2012 Inventor of the Year for the Southern Illinois University System. She was named university-wide Distinguished Scholar for 2014.She authored Essential Audiology for Physicians and edited/authored Pharmacology and Ototoxicity for Audiologists. She has received more than 60 grants from NIH and other agencies for her research in otoprotective agents and is the inventor of the protective agent D-methionine patents. Her patents are owned by her employer, SIU School of Medicine.
Kathleen C. M. Campbell, Ph.D., joined the faculty in surgery at Southern Illinois University School of Medicine in 1989. She is a professor of otolaryngology.
Campbell earned her doctoral degree at the University of Iowa in Iowa City (1989), her master’s at the University of South Dakota in Vermillion and her bachelor’s at South Dakota State University in Brookings (1977, 1973).
Campbell is a member of the American Speech-Language-Hearing Association (ASHA), the American Auditory Society, American Academy of Audiology, American Academy of Otolaryngology – Head and Neck Surgery, Association for Research in Otolaryngology and International Evoked Response Audiometry Study Group. She is an ASHA Fellow, received a special presidential citation from the American Academy of Audiology and received the national 2004 Copper Black Award in Creative Achievement from American Mensa for her inventions on otoprotective agents.
Her research is focused on ototoxicity and otoprotective agents. She has served as principal investigator on more than 60 research grants, funded by agencies such as the Department of Defense, Veterans Administration, the Illinois Department of Public Health and the National Institutes of Health/National Institute of Aging and National Institute of Deafness and Communication Disorders.